GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Resverlogix RVX.TO · CAD

Health Care · Toronto Stock Exchange · 🇨🇦 Canada

Compare

0.08

+6.67%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Resverlogix — daily TSX:RVX Delayed
Market value
C$22.1m
Last close × shares
Volume
70.4k
Shares, 9 Nov 2026

About Resverlogix

Its shares trade on Toronto Stock Exchange under the ticker RVX.TO. It has been listed since 12 October 2001.

Resverlogix Corp. engages in the research and development of pharmaceutical products for cardiovascular diseases. The company is headquartered in Calgary, Alberta. The company went IPO on 2001-10-12. The firm is developing apabetalone (RVX-208), a molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is the BET inhibitor selective for the second bromodomain (BD2) within the BET protein called BRD4. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects for patients with high-risk cardiovascular disease (CVD), diabetes mellitus (DM), chronic kidney disease, dialysis, Alzheimer's disease, Fabry disease, other orphan diseases, and peripheral artery disease. Apabetalone is being studied in a Phase III trial, BETonMACE, in high-risk CVD patients with type 2 DM and low high-density lipoprotein (HDL).

Figures and description from our data supplier, not checked against the company's own report.

More about Resverlogix →

Latest on Resverlogix

Our reporting

We have not reported on Resverlogix yet.

Next results

12 Nov 2026

Due on 12 Nov 2026.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Resverlogix's ticker?

Resverlogix trades as RVX.TO on Toronto Stock Exchange, under ISIN CA76128M1086.

What was Resverlogix's last closing price?

0.08 on 9 Nov 2026. The figure is in CAD and is never converted.

When does Resverlogix next report results?

Results are expected on 12 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.